# Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

> **NCT02285777** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 189 (actual)

## Conditions studied

- Meningococcal Disease

## Interventions

- **BIOLOGICAL:** Meningococcal ABCWY
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02285777
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-01
- **Primary completion:** 2015-03-26
- **Final completion:** 2015-06-11
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2018-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285777, "Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02285777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*